These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26066475)

  • 1. Epidemiologic insights on the role of fibroblast growth factor 23 in cardiovascular disease.
    Scialla JJ
    Curr Opin Nephrol Hypertens; 2015 May; 24(3):260-7. PubMed ID: 26066475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 and the heart.
    Faul C
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):369-75. PubMed ID: 22531163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What would we like to know, and what do we not know about fibroblast growth factor 23?
    Cozzolino M; Galassi A; Apetrii M; Covic A
    J Nephrol; 2011; 24(6):696-706. PubMed ID: 21786227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 and risk of incident stroke in community-living adults.
    Panwar B; Jenny NS; Howard VJ; Wadley VG; Muntner P; Kissela BM; Judd SE; Gutiérrez OM
    Stroke; 2015 Feb; 46(2):322-8. PubMed ID: 25563643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23: a mature renal and cardiovascular risk factor?
    Zoccali C; Yilmaz MI; Mallamaci F
    Blood Purif; 2013; 36(1):52-7. PubMed ID: 23735695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community.
    Ärnlöv J; Carlsson AC; Sundström J; Ingelsson E; Larsson A; Lind L; Larsson TE
    Kidney Int; 2013 Jan; 83(1):160-6. PubMed ID: 22951890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23 and Nutritional Metabolism.
    Pool LR; Wolf M
    Annu Rev Nutr; 2017 Aug; 37():247-268. PubMed ID: 28715994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.
    di Giuseppe R; Kühn T; Hirche F; Buijsse B; Dierkes J; Fritsche A; Kaaks R; Boeing H; Stangl GI; Weikert C
    PLoS One; 2015; 10(7):e0133580. PubMed ID: 26193703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: fibroblast growth factor 23 in phosphate homeostasis and bone metabolism.
    Hori M; Shimizu Y; Fukumoto S
    Endocrinology; 2011 Jan; 152(1):4-10. PubMed ID: 21084445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.
    Hasegawa H; Nagano N; Urakawa I; Yamazaki Y; Iijima K; Fujita T; Yamashita T; Fukumoto S; Shimada T
    Kidney Int; 2010 Nov; 78(10):975-80. PubMed ID: 20844473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
    Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
    Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF23 in Acute and Chronic Illness.
    Schnedl C; Fahrleitner-Pammer A; Pietschmann P; Amrein K
    Dis Markers; 2015; 2015():358086. PubMed ID: 26491212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23 in chronic kidney disease.
    Wahl P; Wolf M
    Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone metabolism and cardiovascular function update. α-klotho/FGF23 system; a new insight into the field of mineral homeostasis and the pathogeneses of aging-associated syndromes and the complications of chronic kidney disease].
    Nabeshima YI
    Clin Calcium; 2014 Jul; 24(7):37-43. PubMed ID: 24976054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.
    Shah NH; Dong C; Elkind MS; Sacco RL; Mendez AJ; Hudson BI; Silverberg S; Wolf M; Rundek T; Wright CB
    Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):2048-53. PubMed ID: 26112008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the role of fibroblast growth factor 23 in chronic kidney disease.
    Nakai K; Komaba H; Fukagawa M
    J Nephrol; 2010; 23(6):619-25. PubMed ID: 20658451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?
    Stubbs JR; Quarles LD
    Nephrol News Issues; 2009 May; 23(6):33-4, 36-7. PubMed ID: 19534362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.